NuGene International, Inc. Announces Record Product Orders in December

IRVINE, Calif., Feb. 12, 2015 /PRNewswire/ -- NuGene International, Inc. ("NuGene") (OTCQB: NUGN), a manufacturer and distributor of proprietary age-defying aesthetic products for skin and hair rejuvenation developed from adult adipose stem cells and other biologically active ingredients, received approximately $320,000 in product orders in December, a record month for product orders since the company completed its successful beta product launch in early 2014.

"NuGene management sees this as strong market validation for our product lines," explained Ali Kharazmi, CEO of NuGene.  "With the increased product demand seen in December 2014, as well as the satisfied customer feedback received to date, we expect double digit growth of our distribution base during 2015. We are an early stage company that began 2014 with a close group of associated aestheticians, medical spas and physicians. We added 50 distribution locations throughout November and December and as of the end of 2014 our product lines have expanded into 75 professional locations."

The company currently markets its products through a network of clinics, medical spas and skin and hair care professionals and has previously announced its intention to build new distribution networks both nationally and internationally. "The results have been extremely positive," noted Mr. Kharazmi, "fueling further interest from several prospective distributors."

About NuGene International, Inc.

NuGene International, Inc. develops, manufactures and markets proprietary regenerative cosmeceutical and pharmaceutical products based on adipose derived human stem cell and human stem cell media.  The US Department of Health and Human Services calls regenerative medicine the "next evolution of medical treatments".  The regenerative medical market which includes cosmeceuticals and pharmaceuticals was estimated at $7.2 Billion in the US in 2014 and is expected to rapidly grow in the coming years according to RNCOS Business Consultancy Services Global Cosmeceuticals Market Report.  NuGene's cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations derived from adult human stem cell derived media obtained from adipose tissue.  NuGene's exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations.  The company has applied for two patents covering 15 unique applications and inventions.  NuGene's goal is to leverage its extensive knowledge and expertise to develop age defying regenerative cosmeceutical skincare and hair care products, in addition to pharmaceutical products, based on the same regenerative science platform.

Forward-Looking Statements

This release contains forward-looking statements. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the possibility that some or all of the matters and transactions considered by NuGene International may not proceed as contemplated, and by all other matters and assumptions specified in NuGene's filings with the Securities and Exchange Commission, especially those risks and other matters described under "Risk Factors" within NuGene's Form 8-K filed with the Commission on January 6, 2015. These statements are made based upon current expectations that are subject to risk and uncertainty. NuGene does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information.

Investor/ Media Relations:
Chris Rosgen
Capital Market Relations
(949)481-9739

Logo - http://photos.prnewswire.com/prnh/20150212/175133LOGO

SOURCE NuGene International, Inc.